Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 2Hemorrhage 2Sexual Infantilism 1Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Myoma 1Myofibroma 1Diabetes Insipidus 1Craniopharyngioma 1Blood Loss, Surgical 1Adenomyosis 1

Interventions

Uterine Myomectomy 2Uterine Artery Embolization 2Saline Solution 2Bupivacaine 2ramosetron 1Triamcinolone Acetonide 1Triamcinolone 1Surveys and Questionnaires 1Salpingectomy 1Robotic Surgical Procedures 1Oxytocin 1Iohexol 1Indocyanine Green 1Incidence 1Ibuprofen 1Hysteroscopy 1Hysterectomy 1High-Energy Shock Waves 1Gonadotropin-Releasing Hormone 1Exome Sequencing 1Endoscopes 1Elasticity Imaging Techniques 1Dexamethasone 1Base Sequence 1Ascorbic Acid 1Anesthesia, Obstetrical 1Analgesia, Patient-Controlled 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenomyosis × Oxytocin × Clear all
NCT03937401 2019-05-03

Oxytocin in MRI-HIFU

Turku University Hospital

Phase 4 Unknown
100 enrolled

Leiomyoma, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡